Suggested Topics within your search.
Suggested Topics within your search.
- methods 5
- Therapeutic use 4
- therapeutic use 4
- Anesthesia 3
- Anesthetics 3
- therapy 3
- Anesthesiology 2
- Biochemistry 2
- Chemistry, Clinical 2
- Chemotherapy 2
- Cognitive Therapy 2
- Health and Fitness 2
- Pharmacology 2
- pharmacology 2
- Analgesia 1
- Analgesics 1
- Anti-Infective Agents 1
- Anti-infective agents 1
- Anxiety Disorders 1
- Child welfare 1
- Clinical Chemistry Tests 1
- Clinical chemistry 1
- Cognitive therapy 1
- Communicable diseases in children 1
- Congresses 1
- Cultural Diversity 1
- Custody of children 1
- Diarrhea, Infantile 1
- Diet therapy 1
- Diet therapy for infants 1
-
3081
New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
Published 2024-07-01“…The affinity-matured human antibody repertoire may be ideal as a source for antibody therapeutics against BoNTs. In an effort to develop novel BoNT type A (BoNT/A) immunotherapeutics, sorted by flow cytometry plasmablasts and activated memory B cells from a donor repeatedly injected with BoNT/A for aesthetic botulinum therapy could be used due to obtain hybridomas producing native antibodies. …”
Get full text
Article -
3082
Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional studyResearch in context
Published 2025-02-01“…This study suggests a framework to investigate screening paradigms for synuclein pathology that could lead to design of therapeutic prevention studies in individuals without symptoms. …”
Get full text
Article -
3083
-
3084
Lucidin from <i>Rubia cordifolia</i> Outperforms FDA-Approved Lapatinib as a Potential Multitargeted Candidate for Breast Cancer Signalling Proteins
Published 2025-01-01“…The multitargeted profile of Lucidin suggests a broader therapeutic approach with potential to overcome resistance and side effects associated with Lapatinib. …”
Get full text
Article -
3085
Deep proteomics and network pharmacology reveal sex- and age-shared neuropathic pain signatures in mouse dorsal root ganglia
Published 2025-01-01“…Proteome signatures represented numerous targets of FDA-approved drugs comprising both (i) known pain therapeutics (e.g. Pregabalin and opioids) and, importantly, (ii) compounds with high potential for future re-purposing, e.g. …”
Get full text
Article -
3086
Fusidic Acid and Lidocaine-Loaded Electrospun Nanofibers as a Dressing for Accelerated Healing of Infected Wounds
Published 2025-01-01“…Khulud A Alsulami,1 Abrar A Bakr,1 Alaa Sirwi,2 Mahmoud A Elfaky,2 Rasheed A Shaik,3 Bayan Y Alshehri,1 Alhassan H Aodah,1 Nojoud Al Fayez,1 Abdullah A Alshehri,1 Fahad A Almughem,1 Abdulrahman A Halwani,4,5 Essam A Tawfik1 1Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh, 11442, Saudi Arabia; 2Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 3Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 4Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 5Regenerative Medicine Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi ArabiaCorrespondence: Essam A Tawfik, Email etawfik@kacst.gov.saIntroduction: Wound treatment is a significant health burden in any healthcare system, which requires proper management to minimize pain and prevent bacterial infections that can complicate the wound healing process.Rationale: There is a need to develop innovative therapies to accelerate wound healing cost-effectively. …”
Get full text
Article -
3087
-
3088
-
3089
I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations
Published 2022-06-01“…Introduction The COVID-19 pandemic brought an urgent need to discover novel effective therapeutics for patients hospitalised with severe COVID-19. …”
Get full text
Article -
3090
Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo
Published 2025-01-01“…This highlights the potential of RNA-targeting CRISPR systems as therapeutics for C9orf72 ALS/FTD.…”
Get full text
Article -
3091
Indigofera suffruticosa Mill. (Anil): Plant Profile, Phytochemistry, and Pharmacology Review
Published 2018-01-01“…Therefore, as an important traditional popular medicine, further studies on I. suffruticosa are required for the development of new drugs and therapeutics for various diseases.…”
Get full text
Article -
3092
Microneedle technology for enhanced topical treatment of skin infections
Published 2025-03-01“…Notably, the advantages of state-of-the-art MNs for treating skin infections are pointed out, which include hijacking sequential drug transport barriers to enhance drug delivery efficiency and delivering various therapeutics (e.g., antibiotics, antimicrobial peptides, photosensitizers, metals, sonosensitizers, nanoenzyme, living bacteria, poly ionic liquid, and nanomoter). …”
Get full text
Article -
3093
A video intervention to improve patient understanding of tumor genomic testing in patients with cancer
Published 2024-09-01Get full text
Article -
3094
-
3095
Epigenetic regulation in coronary artery disease: from mechanisms to emerging therapies
Published 2025-01-01“…Furthermore, we discuss emerging therapeutic strategies targeting epigenetic pathways. …”
Get full text
Article -
3096
Alterations in fecal bacteriome virome interplay and microbiota-derived dysfunction in patients with schizophrenia
Published 2025-01-01“…They reveal that patients with schizophrenia harbor an abnormal virome-bacteriome ecology, shedding light on the potential development of microbial therapeutics.…”
Get full text
Article -
3097
Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma...
Published 2023-12-01“…There remains an urgent unmet need for the development of and access to effective therapeutics for these patients.…”
Get full text
Article -
3098
A comprehensive review on the plant sources, pharmacological activities and pharmacokinetic characteristics of Syringaresinol
Published 2025-02-01“…As the demand for natural therapeutics increases, Syringaresinol has garnered significant attention for its pharmacological properties. …”
Get full text
Article -
3099
-
3100